Anti-HBeAg Intrabody [(D-Arg)9] (IAB-B037(A))
Recombinant anti-HBeAg intrabody linked to (D-Arg)9 works within cells and binds specifically to HBeAg, expressed in E. coli cells. The development of new therapies that target viral proteins, such as HBeAg, which regulates of the immune system, may offer a new wave of potential therapeutics to circumvent progression to CHB and liver disease.
Specifications
- Immunogen
- hepatitis B e antigen
- Host
- llama
- Type
- vhh-(D-Arg)9
- Cell Penetrating Peptide
- (D-Arg)9
It has been proven that polyarginine peptides composed of nine arginine amino acids (Arg-9) are able to translocate across cells very efficiently. This raises the question if molecular dynamics simulations would show a similar pathway for this highly hydrophilic and charged peptide as predicted for the Tat peptide. The simplicity of Arg-9 over other CPPs also helps isolate the role of the Arg sidechain on the translocation without the effect of other sidechains. Therefore, in this work we study computationally the translocation of Arg-9 through a lipid bilayer and show that the translocation mechanism is the same as for the Tat peptide.
- Species Reactivity
- HBV
- Applications
- Used for immunoassay techniques such as: Western blot; Immunocytochemistry; Functional studies
Target
- Alternative Names
- HBeAg; hepatitis B e antigen; Core antigen; Core protein antibody; HBe antigen; HBeAg; HBVgp4; Pre C,C
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: